Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.74 |
| ▸ | CA12 | O43570 | 3/20 | 0.62 |
| ▸ | CA1 | P00915 | 3/20 | 0.62 |
| ▸ | CA2 | P00918 | 3/20 | 0.62 |
| ▸ | CA9 | Q16790 | 3/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ABL1 | P00519 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | IDE | P14735 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | PLCD1 | P51178 | 1/20 | 0.60 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.57 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.57 |
| ▸ | HLCS | P50747 | 1/20 | 0.57 |
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13049579 | 1.00 | TDP1 (0.74) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL316398 | 1.00 | TDP1 (0.74) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL10308271 | 1.00 | TDP1 (0.74) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL13065003 | 1.00 | TDP1 (0.74) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL9733492 | 1.00 | TDP1 (0.74) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL288457 | 1.00 | TDP1 (0.74) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL20375017 | 1.00 | TDP1 (0.74) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL10140226 | 1.00 | TDP1 (0.74) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL5437180 | 1.00 | TDP1 (0.74) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL20483620 | 1.00 | TDP1 (0.74) | TDP1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4646595-A1 | PEPTIDE SEQUENCER | Oregon Health & Science University (US) | 2025-11-12 | — | — | EP | disclosed |
| WO-2024148174-A1 | PEPTIDE SEQUENCER | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2024-07-11 | — | — | WO | disclosed |
| US-20220389478-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | ORYZON GENOMICS SA (ES) | 2022-12-08 | — | — | US | disclosed |
| US-20220120739-A1 | CHIPS, DETECTORS, AND METHODS OF MAKING AND USING THE SAME | SENTILUS HOLDCO, LLC | 2022-04-21 | — | — | US | disclosed |
| US-11169150-B2 | Chips, detectors, and methods of making and using the same | Sentilus Holdco LLC (US) | 2021-11-09 | — | — | US | disclosed |
| US-11130987-B2 | Direct detection of RNA by surface initiated enzymatic polymerization | SENTILUS HOLDCO, LLC (US) | 2021-09-28 | — | — | US | disclosed |
| US-11034991-B2 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | ORYZON GENOMICS S.A. (ES) | 2021-06-15 | — | — | US | disclosed |
| EP-3325966-B1 | CHIPS, DETECTORS, AND METHODS OF MAKING AND USING THE SAME | Sentilus Holdco LLC (US) | 2021-01-20 | — | — | EP | disclosed |
| US-20190085372-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | ORYZON GENOMICS SA (ES) | 2019-03-21 | — | — | US | disclosed |
| EP-3430015-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | Oryzon Genomics, S.A. (ES) | 2019-01-23 | — | — | EP | disclosed |
| US-9422602-B2 | Methods and compositions for determining nucleic acid degradation | BIO-RAD LABORATORIES, INC. (US) | 2016-08-23 | — | — | US | disclosed |
| WO-2015081088-A1 | DIRECT DETECTION OF RNA BY SURFACE INITIATED ENZYMATIC POLYMERIZATION | IMMUCOR, GTT DIAGNOSTICS, INC. (US) | 2015-06-04 | — | — | WO | disclosed |
| US-20140051595-A1 | Methods and Compositions for Determining Nucleic Acid Degradation | BIO-RAD LABORATORIES, INC. (US) | 2014-02-20 | — | — | US | disclosed |
| EP-0876385-B1 | TOPIRAMATE IMMUNOASSAY, AS WELL AS ANALOGS AND ANTIBODIES | OPUS DIAGNOSTICS INC (US) | 2000-10-18 | — | — | EP | disclosed |
| US-6030846-A | Homogeneous assays using avidin-binding azo reagents | DADE BEHRING INC. (US) | 2000-02-29 | — | — | US | disclosed |
| US-5952187-A | ANTIEPILEPTIC AGENT ANALOG DERIVATIZED AT THE SULFAMATE MOIETY OR THE 9-CARBON METHYL GROUP TO ADD LABEL FOR USE IN IMMUNOASSAYS OR TO ADD CARRIER FOR USE AS IMMUNOGEN; FOR MONITORING SERUM OR PLASMA LEVELS OF DRUG | OXIS INTERNATIONAL, INC. (US) | 1999-09-14 | — | — | US | disclosed |
| EP-0876385-A1 | TOPIRAMATE IMMUNOASSAY, AS WELL AS ANALOGS AND ANTIBODIES | Oxis International, Inc. (US) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997019950-A1 | TOPIRAMATE IMMUNOASSAY, AS WELL AS ANALOGS AND ANTIBODIES | OXIS INTERNATIONAL, INC. (US) | 1997-06-05 | — | — | WO | disclosed |
| US-5612221-A | Avidin-binding fluorescing and quenching reagent for use in homogeneous assays | DADE CHEMISTRY SYSTEMS INC. (US) | 1997-03-18 | — | — | US | disclosed |
| US-5536820-A | Avidin-binding azo reagents | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220389478-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | KDM1B, KDM1A, KDM7A | TDP1 1918/4885CA12 2752/4885CA1 1658/4885 |
| US-20190085372-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | KDM1B, KDM1A, KDM7A | TDP1 1918/4885CA12 2752/4885CA1 1658/4885 |
| US-11034991-B2 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | KDM1B, KDM1A, KDM7A | TDP1 1918/4885CA12 2752/4885CA1 1658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.